# Digzyme

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/digzyme

- Industry: Biotechnology
- Headquarters: Tokyo, Japan
- Website: www.digzyme.com/
- Total disclosed funding: $2.5M
- Latest round: Series A (Apr 23, 2024)
- Investors on record: 8

## About

Founded in 2019 and based in Tokyo, Japan, Digzyme Inc. operates as an enzyme discovery firm that uses AI to accelerate the discovery and design of enzymes. The company was founded by its CEO, Naoo Torai, CTO Yuya Nakamura, and CSO Takuji Yamada. In April 2024, digzyme Inc. raised venture debt funding from unspecified investors. This round was part of a larger JPY 730 million in equity and debt funding.

Digzyme offers a bioinformatics platform that utilizes artificial intelligence to analyze vast amounts of life science data to identify and optimize enzymes for industrial applications. The company offers a range of services, including enzyme discovery, enzyme design, and enzyme library creation.

The company plans to use the funds raised in April 2024 to accelerate the development of its enzyme library.

## Funding rounds

- Series A, Apr 23, 2024, $2.2M — Mobile Internet Capital, ANRI, Miraisozo Investments, DG Daiwa Ventures, Moriroku, HERO, Fuji Nihon Seito Corporation
- Seed, May 29, 2020, $0.3M — ANRI, ReBoost Inc.

## Investors

- ANRI (https://capitalatlas.ai/funds/anri) — Seed, Series A
- ReBoost Inc. — Seed
- Mobile Internet Capital (https://capitalatlas.ai/funds/mobile-internet-capital) — Series A
- Miraisozo Investments (https://capitalatlas.ai/funds/miraisozo-investments) — Series A
- DG Daiwa Ventures (https://capitalatlas.ai/funds/dg-daiwa-ventures) — Series A
- Moriroku — Series A
- HERO (https://capitalatlas.ai/funds/hero) — Series A
- Fuji Nihon Seito Corporation — Series A